Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Miaoting Yang"'
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Endoplasmic reticulum (ER) stress, promoting lipid metabolism disorders and steatohepatitis, contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablets (HQT) has a definite eff
Externí odkaz:
https://doaj.org/article/a041cfa7af644588afee60bf6564ef6e
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Previous studies have found that Hugan Qingzhi tablet (HQT) has significant lipid-lowering and antioxidant effects on non-alcoholic fatty liver disease (NAFLD). Moreover, the results of proteomic analysis confirmed that various pr
Externí odkaz:
https://doaj.org/article/d0b9c48eae3e48b689a9bc3237dbd4b4
Publikováno v:
Data in Brief, Vol 15, Iss , Pp 612-614 (2017)
The data presented in this article are related to the research article entitled âIsobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease i
Externí odkaz:
https://doaj.org/article/e0a8b60e09a4461a9f64b87edb4aada2
Publikováno v:
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-14 (2020)
Background Previous studies have found that Hugan Qingzhi tablet (HQT) has significant lipid-lowering and antioxidant effects on non-alcoholic fatty liver disease (NAFLD). Moreover, the results of proteomic analysis confirmed that various proteins in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c87ebe0ea5b993623e94f42e675a9b
https://pubmed.ncbi.nlm.nih.gov/33308192
https://pubmed.ncbi.nlm.nih.gov/33308192
Additional file 2. Blot images.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15693b35f11f986f931c7ef581398ea4
Publikováno v:
Data in Brief, Vol 15, Iss, Pp 612-614 (2017)
Data in Brief
Data in Brief
The data presented in this article are related to the research article entitled “Isobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdc7505bd2e0e63a40eb231ad1cffac
https://doi.org/10.1016/j.dib.2017.10.027
https://doi.org/10.1016/j.dib.2017.10.027
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 38(11)
OBJECTIVE: To investigate the effects of sera from rats fed with Huganqingzhi tablets (HGT) on endoplasmic reticulum (ER) stress in a steatotic hepatocyte model of free fatty acids (FFAs)-induced nonalcoholic fatty liver disease (NAFLD) and explore t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03a231b3230afdd481a86dbcecf0e10d
https://pubmed.ncbi.nlm.nih.gov/30514673
https://pubmed.ncbi.nlm.nih.gov/30514673
Publikováno v:
Frontiers in Pharmacology
In previous research, Hugan Qingzhi, a traditional Chinese medicine, was shown to have protective effects against hepatic steatosis. However, its activity against nonalcoholic fatty liver disease (NAFLD) and the mechanisms by which it exerts its effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83daa9127738e701e2d8de2471d39d9
https://doi.org/10.3389/fphar.2017.00099
https://doi.org/10.3389/fphar.2017.00099
Publikováno v:
Journal of ethnopharmacology. 212
Ethnopharmacological relevance Hugan Qingzhi tablet (HQT), a traditional Chinese medicine formula has been adopted for preventing and treating nonalcoholic fatty liver disease (NAFLD). Aim In order to explore the anti-NAFLD mechanisms of HQT, iTRAQ-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e3076156f02b24a589a574044328be
https://pubmed.ncbi.nlm.nih.gov/29031784
https://pubmed.ncbi.nlm.nih.gov/29031784
Publikováno v:
Pharmacognosy Magazine. 14:597
Background: Alismatis Rhizoma (AR) is a traditional Chinese medicine that is frequently used for the treatment of hyperlipidemia, hypertension, diabetes, and chronic kidney failure. Active alisols contribute to the beneficial effects of AR and AR pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a644602347860278b9cf9e0ec6c8e5
https://doi.org/10.4103/pm.pm_614_17
https://doi.org/10.4103/pm.pm_614_17